Agilon Health
179 hedge funds and large institutions have $1.73B invested in Agilon Health in 2026 Q2 according to their latest regulatory filings, with 93 funds opening new positions, 37 increasing their positions, 36 reducing their positions, and 9 closing their positions.
1,319% more capital invested
Capital invested by funds: $122M → $1.73B (+$1.61B)
933% more first-time investments, than exits
New positions opened: 93 | Existing positions closed: 9
245% more call options, than puts
Call options by funds: $117M | Put options by funds: $34.1M
93.31% more ownership
Funds ownership: 3.73% → 97.04% (+93%)
85% more funds holding
Funds holding: 97 → 179 (+82)
33% more funds holding in top 10
Funds holding in top 10: 3 → 4 (+1)
3% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 36
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Marshall Wace
London,
United Kingdom
|
+$30.7M |
| 2 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
+$28.9M |
| 3 |
BlackRock
New York
|
+$17.9M |
| 4 |
Jane Street
New York
|
+$16.9M |
| 5 |
Nuveen
Charlotte,
North Carolina
|
+$12.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$24.6M |
| 2 |
D.E. Shaw & Co
New York
|
-$23.1M |
| 3 |
AQR Capital Management
Greenwich,
Connecticut
|
-$18.5M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$17.4M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$14.2M |
AGL Hedge Fund Activity: Q2 2026 in Review
179 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in Agilon Health (AGL) for Q2 2026, worth a combined $1.73B — up 1,319% from $122M a quarter earlier.
Buyers outnumbered sellers: 93 funds opened new AGL positions and 9 closed out — a net gain of 84 holders — while 37 added to existing stakes and 36 trimmed.
The largest buyer was Marshall Wace, opening a new position worth an estimated $30.7M. The largest seller was Goldman Sachs, cutting an estimated $24.6M.
- 179 institutional investors held Agilon Health (AGL) as of Q2 2026, up from 97 in Q1 2026.
- Funds reported $1.73B of Agilon Health stock for Q2 2026, up 1,319% quarter-over-quarter.
- 93 funds opened new Agilon Health positions in Q2 2026 and 9 closed out, a net change of +84 holders.
- The largest Agilon Health buyer in Q2 2026 was Marshall Wace, an estimated $30.7M added.
- The largest Agilon Health seller in Q2 2026 was Goldman Sachs, an estimated $24.6M sold.
Based on aggregated 13F filings for Q2 2026.